Optimizing Drug Formulations for Pediatric and Geriatric Populations

Abstract

As the demographics of global populations continue to shift towards aging societies and pediatric healthcare remains a critical focus, optimizing drug formulations for both pediatric and geriatric populations becomes increasingly imperative. This abstract explores the unique challenges and considerations in formulating pharmaceuticals tailored to these distinct age groups. Pediatric patients present a spectrum of physiological differences compared to adults, including variations in metabolic rates, organ functions, and body compositions. Consequently, drug formulations for this demographic necessitate precise dosing, palatable taste, and suitable dosage forms to ensure safety, efficacy, and compliance.